Key Insights

Highlights

Success Rate

86% trial completion

Published Results

227 trials with published results (22%)

Research Maturity

680 completed trials (65% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

10.5%

110 terminated out of 1049 trials

Success Rate

86.1%

-0.4% vs benchmark

Late-Stage Pipeline

33%

349 trials in Phase 3/4

Results Transparency

33%

227 of 680 completed with results

Key Signals

227 with results86% success110 terminated

Data Visualizations

Phase Distribution

833Total
Not Applicable (239)
Early P 1 (4)
P 1 (57)
P 2 (184)
P 3 (220)
P 4 (129)

Trial Status

Completed680
Unknown115
Terminated110
Recruiting57
Withdrawn36
Not Yet Recruiting24

Trial Success Rate

86.1%

Benchmark: 86.5%

Based on 680 completed trials

Clinical Trials (1049)

Showing 20 of 20 trials
NCT00106015RecruitingPrimary

Diamond Blackfan Anemia Registry (DBAR)

NCT07025512Phase 2Suspended

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

NCT05773586Phase 1RecruitingPrimary

A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.

NCT06968936Not ApplicableRecruitingPrimary

Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy

NCT00843882Phase 3Active Not RecruitingPrimary

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

NCT07516847Phase 2Not Yet Recruiting

Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes

NCT01572506Phase 1CompletedPrimary

Mechanisms Accounting for Unexplained Anemia in the Elderly

NCT06976918Recruiting

Registry Platform Myelofibrosis and Anemia

NCT05211037Not ApplicableCompletedPrimary

Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease

NCT07368972Phase 2Recruiting

Study of DISC-0974-201 in Participants With IBD and Anemia

NCT07493772Not ApplicableNot Yet RecruitingPrimary

Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania

NCT06788691Phase 2Recruiting

Luspatercept for Clonal Cytopenias of Uncertain Significance

NCT05664737Phase 2RecruitingPrimary

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

NCT07308769Phase 4RecruitingPrimary

Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

NCT03037164Phase 3Active Not RecruitingPrimary

INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections

NCT03850964Phase 2Active Not Recruiting

Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)

NCT07478575Active Not Recruiting

Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure

NCT07459816Not ApplicableRecruitingPrimary

Genomic of CONgenital Sideroblastic Anemias

NCT07463612Not Yet RecruitingPrimary

The Influence of Anemia on HbA1c Readings in Non-Diabetic Patients

NCT05320198Phase 1Recruiting

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Scroll to load more

Research Network

Activity Timeline